[Hypothesis of Genetic Diversity Selection in the Occurrence and Development of Lung Cancer: Molecular Evolution and Clinical Significance]
- PMID: 38163980
- PMCID: PMC10767663
- DOI: 10.3779/j.issn.1009-3419.2023.101.34
[Hypothesis of Genetic Diversity Selection in the Occurrence and Development of Lung Cancer: Molecular Evolution and Clinical Significance]
Abstract
So far, the monoclonal hypothesis of tumor occurrence and development cannot be justified. The genetic diversity selection hypothesis for the occurrence and development of lung cancer links Mendelian genetics with Darwin's theory of evolution, suggesting that the genetic diversity of tumor cell populations with polyclonal origins-monoclonal selection-subclonal expansion is the result of selection pressure. Normal cells acquire mutations in oncogenic driver genes and have a selective advantage over other cells, becoming tumor initiating cells; In the interaction with the tumor microenvironment (TME), the vast majority of initiating cells are recognized and killed by the human immune system. If immune escape occurs, the incidence of malignant tumors will greatly increase, and subclonal expansion, intratumour heterogeneity, etc. will occur. This article proposed the hypothesis of genetic diversity selection and analyzed its clinical significance. .
【中文题目:肺癌发生发展的遗传多样性选择假说 ——分子进化与临床意义】 【中文摘要:到目前为止,阐述肿瘤发生发展的单克隆假说不能自圆其说。遗传多样性选择假说将孟德尔遗传学与达尔文进化论联系起来,认为多克隆起源-单克隆选择-亚克隆扩张的肿瘤细胞群遗传多样性是选择压力的结果。正常细胞获得致癌驱动基因突变,相对于其他细胞具有选择优势,成为肿瘤启动细胞;在与肿瘤微环境(tumor microenvironment, TME)的互动中,绝大多数启动细胞会被人体自身免疫系统识别并杀灭,如果发生免疫逃逸,恶性肿瘤的发生率会极大增加,并发生亚克隆扩张、肿瘤内异质性等。本文提出遗传多样性选择假说,并分析其临床意义。 】 【中文关键词:肺肿瘤;遗传多样性;选择;分子进化;临床意义】.
Keywords: Clinical significance; Genetic diversity; Lung neoplasms; Molecular evolution; Selection.
Similar articles
-
Why is cancer not more common? A changing microenvironment may help to explain why, and suggests strategies for anti-cancer therapy.Open Biol. 2020 Apr;10(4):190297. doi: 10.1098/rsob.190297. Epub 2020 Apr 15. Open Biol. 2020. PMID: 32289242 Free PMC article.
-
Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.J Thorac Oncol. 2019 Nov;14(11):1912-1923. doi: 10.1016/j.jtho.2019.07.031. Epub 2019 Aug 22. J Thorac Oncol. 2019. PMID: 31446140 Free PMC article.
-
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.Cancer Biol Med. 2020 Aug 15;17(3):768-781. doi: 10.20892/j.issn.2095-3941.2020.0121. Cancer Biol Med. 2020. PMID: 32944405 Free PMC article.
-
Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity.Elife. 2022 Sep 8;11:e79895. doi: 10.7554/eLife.79895. Elife. 2022. PMID: 36074553 Free PMC article. Review.
-
Oncogene addiction and tumor mutational burden in non-small-cell lung cancer: Clinical significance and limitations.Thorac Cancer. 2020 Feb;11(2):205-215. doi: 10.1111/1759-7714.13246. Epub 2019 Dec 4. Thorac Cancer. 2020. PMID: 31799812 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical